Impact of concomitant medication use on belimumab efficacy and safety in patients with systemic lupus erythematosus

Practicing physicians have requested efficacy and safety data for belimumab, when used with specific systemic lupus erythematosus (SLE) medications. This was a post hoc analysis of pooled efficacy and safety data from patients who received belimumab 10 mg/kg plus standard of care (SoC) or placebo (S...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwarting, A, Dooley, M A, Roth, D A, Edwards, L, Thompson, A, Wilson, B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089223/
https://www.ncbi.nlm.nih.gov/pubmed/27488472
http://dx.doi.org/10.1177/0961203316655215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089223/
https://www.ncbi.nlm.nih.gov/pubmed/27488472
http://dx.doi.org/10.1177/0961203316655215

Ejemplares similares